Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
07/2012
07/04/2012CN101579381B Medicinal composition for treating diabetes mellitus
07/04/2012CN101574392B Prevention and treatment of diseases induced by microcirculation disturbance with total salvianolic acid
07/04/2012CN101564160B Food for preventing and treating hyperlipemia and hyperglycemia and preparation method thereof
07/04/2012CN101564159B Food for reducing hypertension and diabetes and preparation method thereof
07/04/2012CN101513405B Use of chemotherapeutic agents
07/04/2012CN101506165B Phenyl, pyridine and quinoline derivatives
07/04/2012CN101463081B GLP-1 derivative
07/04/2012CN101454289B Substituted tetrahydroisoquinoline compounds, their preparation and use in medicaments
07/04/2012CN101405016B Lypolysis promoter
07/04/2012CN101396450B Shenfen capsules
07/04/2012CN101396397B Medicine composition for preventing the birth defect and improving the memory
07/04/2012CN101389353B Enteric gelatinous nutrient and method of preparing the same
07/04/2012CN101380390B Preparation method of Pu-Er ripe tea standard extract PRC-001 and preparation method and use thereof
07/04/2012CN101375906B Pharmaceutical combination for preventing birth-defect and improving memory
07/04/2012CN101375896B Pharmaceutical combination for preventing birth-defect and improving memory
07/04/2012CN101366873B Medicament composition for preventing birth defect and improving memory
07/04/2012CN101366872B Medicament composition for preventing birth defect and improving memory
07/04/2012CN101366864B Medicament composition for preventing birth defect and improving memory
07/04/2012CN101366863B Medicament composition for preventing birth defect and improving memory
07/04/2012CN101366841B Medicament composition for preventing birth defection and improving memory
07/04/2012CN101366823B Medicament composition for preventing birth defect and improving memory
07/04/2012CN101366788B Medicament composition for preventing birth defect and improving memory
07/04/2012CN101366783B Medicament composition for preventing birth defection and improving memory
07/04/2012CN101366777B Medicament composition for preventing birth defection and improving memory
07/04/2012CN101366776B Medicament composition for preventing birth defection and improving memory
07/04/2012CN101366774B Medicament composition for preventing birth defection and improving memory
07/04/2012CN101366750B Medicament composition for preventing birth defect and improving memory
07/04/2012CN101366746B Pharmaceutical combination for preventing birth defect and improving anamnesis
07/04/2012CN101357174B Medicinal composition for treating diabetes
07/04/2012CN101347235B Cicer arietinum lipid-lowering nourishing powder and method of preparing the same
07/04/2012CN101317850B Sucrose absorption inhibitor
07/04/2012CN101296693B 持久力提高剂 Endurance enhancing agent
07/04/2012CN101274006B Pharmaceutical combination of prepotency for preventing birth-defect and improving memory
07/04/2012CN101274002B Pharmaceutical combination of prepotency for preventing birth-defect and improving memory
07/04/2012CN101228911B Tea for nourishing face and eliminating toxin
07/04/2012CN101199581B Chick-pea embryo and bean sprout valid part, preparing method and application thereof
07/04/2012CN101147587B Calcium-phosphorus mixture and its use
07/04/2012CN101115763B Novel polyphenol glycoside derived from acerola
07/04/2012CN101106987B Metabolic syndrome-improving agent and medicine, supplement, functional food and food additive containing the same
07/04/2012CN101057968B Oxyntomodulin for preventing or treating excess weight
07/03/2012US8212057 Pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
07/03/2012US8212040 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and thereof
07/03/2012US8211945 Carba-sugar amine derivative and glycolipid metabolic disorder treating agent containing the same as active ingredient
07/03/2012US8211884 2,2-Dimethyl-4-oxo-4-(4-{4-[(2-phenyl-5-trifluoromethyl-oxazole-4-carbonyl)-amino]-phenyl}-[1,4]diazepan-1-yl)-butyric acid, hydrochloride; obesity, type II diabetes mellitus and metabolic syndrome
07/03/2012US8211853 Method of promoting apoptosis of differentiated adipocytes and increasing endogenous expression of SFRP-5 peptide by administration of SFRP-5 peptide
07/03/2012US8211439 Albumin fusion proteins comprising insulin polypeptides
07/03/2012CA2640956C B7rp-1 polypeptides
07/03/2012CA2522248C Methods of treatment using specific binding agents of human angiopoietin-2
07/03/2012CA2474894C Desaturase genes, enzymes encoded thereby, and uses thereof
07/03/2012CA2463814C Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain
07/03/2012CA2445577C Subcellular targeting of therapeutic proteins
07/03/2012CA2409647C Methods of treating androgen deficiency in men using selective antiestrogens
07/03/2012CA2406132C Ligand for herpes simplex virus entry mediator and methods of use
07/03/2012CA2388818C C-aryl glucoside sglt2 inhibitors and method
07/03/2012CA2318052C Antibodies against human il-12
06/2012
06/28/2012WO2012088434A2 Compositions relating to a phosphoprotein and methods of use
06/28/2012WO2012088379A2 Methods for treating metabolic disorders and obesity with gip and glp-1 receptor-active glucagon-based peptides
06/28/2012WO2012088038A2 Piperazinone-substituted tetrahydro-carboline mch-1 antagonists, methods of making, and uses thereof
06/28/2012WO2012087519A1 Compositions and methods for modulating fxr
06/28/2012WO2012086812A1 Glycoside compound
06/28/2012WO2012086811A1 Food intake suppressant and anti-obesity agent
06/28/2012WO2012086735A1 Condensed heterocyclic compound
06/28/2012WO2012086593A1 Viscous nutritional composition
06/28/2012WO2012086406A1 Glp-1 secretagogue
06/28/2012WO2012085785A1 Combination and composition for treating obesity
06/28/2012WO2012085745A1 Glucagon receptor modulators
06/28/2012WO2012085648A1 Phosphorus-substituted quinoxaline-type piperidine compounds and uses thereof
06/28/2012WO2012085645A1 Polymorphs of 3-chloro-4[(2r)-2
06/28/2012WO2012085266A2 Composition comprising cinnamon extract
06/28/2012WO2012085244A1 Pyrimidinone derivatives, preparation thereof and pharmaceutical use thereof
06/28/2012WO2012085071A1 Process for the preparation of a pharmaceutical composition comprising a low soluble pharmaceutically active ingredient
06/28/2012WO2012084999A1 Prokineticin 1 receptor agonists and their uses
06/28/2012WO2012083414A1 Use of marihuana and compounds therein for treating obesity
06/28/2012WO2012067427A9 Pharmaceutical composition containing lk8 protein as an active ingredient for preventing or treating diabetic retinopathy or age-related macular degeneration
06/28/2012WO2012060590A3 Hydrate of 1-{(2s)-2-amino-4-[2,4-bis(trifluoromethyl)-5,8-di- hydropyrido[3,4-d]pyrimidin-7(6h)-yl]-4-oxobutyl}-5,5-difluoro-piperidin-2-one tartrate
06/28/2012WO2012040444A3 Treatment of patients with incipient alzheimer's disease
06/28/2012WO2012040082A3 Antidiabetic solid pharmaceutical compositions
06/28/2012US20120165393 Peptide-Based In Vivo siRNA Delivery System
06/28/2012US20120165391 Use of inhibitors of zdhhc2 activity for modulation of adipogenesis
06/28/2012US20120165382 Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response
06/28/2012US20120165378 Thiophene-carboxamides useful as inhibitors of protein kinases
06/28/2012US20120165377 Agent for reducing visceral fat weight
06/28/2012US20120165375 Urea Glucokinase Activators
06/28/2012US20120165372 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
06/28/2012US20120165368 Pyrazolopyridine kinase inhibitors
06/28/2012US20120165362 Androgen receptor modulator compounds and methods
06/28/2012US20120165353 Novel phenylpyridine derivative and medicinal agent comprising same
06/28/2012US20120165343 Glucagon Receptor Modulators
06/28/2012US20120165337 Tetrahydroquinoxaline urea derivatives, preparation thereof, and therapeutic use thereof
06/28/2012US20120165330 Quinazolinone and related analogs as sirtuin modulators
06/28/2012US20120165329 Compounds and methods for kinase modulation, and indications therefor
06/28/2012US20120165326 Derivatives of 6-(6-substituted-triazolopyridazine-sulfanyl) 5-fluoro benzothiazoles and 5-fluoro benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
06/28/2012US20120165318 Heterocyclic compounds for the inhibition of pask
06/28/2012US20120165312 Fused heterocyclic compound and use thereof
06/28/2012US20120165307 Azaindoles useful as inhibitors of janus kinases
06/28/2012US20120165304 6,7,8,9-Tetrahydro-5H-1,4,7,10a-tetraaza-cyclohept[f]indene derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing them
06/28/2012US20120165303 Triazolyl phenyl benzenesulfonamides
06/28/2012US20120165300 Diastereomers of 2-methylene-19-nor-22-methyl-1alpha,25-dihydroxyvitamin d3
06/28/2012US20120165294 4,5-dihydro-oxazol-2yl derivatives
06/28/2012US20120165292 METHODS FOR TREATMENT OF MULTIPLE MYELOMA USING CYCLOPROPANE CARBOXYLIC ACID {2-(Is)-(3-eTHOXY-4METHOXY-PHENYL)-2-METHANESULFONYL-ETHYL}-3-OXO-2.3-DIHYDRO-1H-ISOINDOL-4-YL}-AMIDE
1 ... 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 ... 1298